{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:29:33Z","timestamp":1791851373350,"version":"4.3.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T00:00:00Z","timestamp":1728432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T00:00:00Z","timestamp":1728432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"AstraZeneca K. K"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chronic kidney disease (CKD) poses significant health risks due to its asymptomatic nature in early stages and its association with increased cardiovascular and kidney events. Early detection and management are critical for improving outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to develop and validate a prediction model for hospitalization for ischemic heart disease (IHD) or cerebrovascular disease (CVD) and major kidney events in Japanese individuals with mild CKD using readily available health check and prescription data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective cohort study was conducted using data from approximately\u00a0850,000 individuals in the PREVENT Inc. database, collected between April 2013 and April 2023. Cox proportional hazard regression models were utilized to derive and validate risk scores for hospitalization for IHD\/CVD and major kidney events, incorporating traditional risk factors and CKD-specific variables. Model performance was assessed using the concordance index (c-index) and 5-fold cross-validation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 40,351 individuals were included. Key predictors included age, sex, diabetes, hypertension, and lipid levels for hospitalization for IHD\/CVD and major kidney events. Age significantly increased the risk score for both hospitalization for IHD\/CVD and major kidney events. The baseline 5-year survival rates are 0.99 for hospitalization for IHD\/CVD and major kidney events are 0.99. The developed risk models demonstrated predictive ability, with mean c-indexes of 0.75 for hospitalization for IHD\/CVD and 0.69 for major kidney events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This prediction model offers a practical tool for early identification of Japanese individuals with mild CKD at risk for hospitalization for IHD\/CVD and major kidney events, facilitating timely interventions to improve patient outcomes and reduce healthcare costs. The models stratified patients into risk categories, enabling identification of those at higher risk for adverse events. Further clinical validation is required.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-024-03786-6","type":"journal-article","created":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T13:02:32Z","timestamp":1728478952000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Development and validation of a prediction model for people with mild chronic kidney disease in Japanese individuals"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0648-2675","authenticated-orcid":false,"given":"Takahiro","family":"Miki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiya","family":"Sakoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kojiro","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kento","family":"Takeyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Hagiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Imaizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,9]]},"reference":[{"key":"3786_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.kisu.2021.11.003","volume":"12","author":"CP Kovesdy","year":"2022","unstructured":"Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl. 2022;12:7\u201311.","journal-title":"Kidney Int Suppl"},{"key":"3786_CR2","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1001\/jama.2019.14745","volume":"322","author":"TK Chen","year":"2019","unstructured":"Chen TK, Knicely DH, Grams ME. Chronic kidney disease diagnosis and management: a review. JAMA. 2019;322:1294\u2013304.","journal-title":"JAMA"},{"key":"3786_CR3","doi-asserted-by":"publisher","first-page":"19595","DOI":"10.1038\/s41598-019-56102-w","volume":"9","author":"TR Oh","year":"2019","unstructured":"Oh TR, Choi HS, Kim CS, Bae EH, Oh YK, Kim Y-S, et al. Association between health related quality of life and progression of chronic kidney disease. Sci Rep. 2019;9:19595.","journal-title":"Sci Rep"},{"key":"3786_CR4","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","volume":"117","author":"RB D\u2019Agostino","year":"2008","unstructured":"D\u2019Agostino RB, Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117:743\u201353.","journal-title":"Circulation"},{"key":"3786_CR5","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/S0195-668X(03)00114-3","volume":"24","author":"RM Conroy","year":"2003","unstructured":"Conroy RM, Py\u00f6r\u00e4l\u00e4 K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003;24:987\u20131003.","journal-title":"Eur Heart J"},{"key":"3786_CR6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jacc.2007.03.037","volume":"50","author":"DE Weiner","year":"2007","unstructured":"Weiner DE, Tighiouart H, Elsayed EF, Griffith JL, Salem DN, Levey AS, et al. The Framingham predictive instrument in chronic kidney disease. J Am Coll Cardiol. 2007;50:217\u201324.","journal-title":"J Am Coll Cardiol"},{"key":"3786_CR7","doi-asserted-by":"crossref","unstructured":"Chen S-C, Su H-M, Tsai Y-C, Huang J-C, Chang J-M, Hwang S-J et al. Framingham risk score with cardiovascular events in chronic kidney disease. PLoS ONE. 2013;8: e60008.","DOI":"10.1371\/journal.pone.0060008"},{"key":"3786_CR8","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.jclinepi.2012.06.020","volume":"66","author":"GS Collins","year":"2013","unstructured":"Collins GS, Omar O, Shanyinde M, Yu L-M. A systematic review finds prediction models for chronic kidney disease were poorly reported and often developed using inappropriate methods. J Clin Epidemiol. 2013;66:268\u201377.","journal-title":"J Clin Epidemiol"},{"key":"3786_CR9","doi-asserted-by":"publisher","first-page":"100552","DOI":"10.1016\/j.eclinm.2020.100552","volume":"27","author":"K Matsushita","year":"2020","unstructured":"Matsushita K, Jassal SK, Sang Y, Ballew SH, Grams ME, Surapaneni A, et al. Incorporating kidney disease measures into cardiovascular risk prediction: development and validation in 9 million adults from 72 datasets. EClinicalMedicine. 2020;27:100552.","journal-title":"EClinicalMedicine"},{"key":"3786_CR10","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","volume":"375","author":"K van der Matsushita","year":"2010","unstructured":"Chronic Kidney Disease Prognosis Consortium, van der Matsushita K, Astor BC, Woodward M, Levey AS, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375:2073\u201381.","journal-title":"Lancet"},{"key":"3786_CR11","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1161\/CIRCULATIONAHA.114.014508","volume":"131","author":"GS Collins","year":"2015","unstructured":"Collins GS, Reitsma JB, Altman DG, Moons KGM, TRIPOD Group. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. The TRIPOD Group. Circulation. 2015;131:211\u20139.","journal-title":"Circulation"},{"key":"3786_CR12","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1093\/ndt\/gfx371","volume":"34","author":"H Mukai","year":"2019","unstructured":"Mukai H, Svedberg O, Lindholm B, Dai L, Heimb\u00fcrger O, Barany P, et al. Skin autofluorescence, arterial stiffness and Framingham risk score as predictors of clinical outcome in chronic kidney disease patients: a cohort study. Nephrol Dial Transpl. 2019;34:442\u20138.","journal-title":"Nephrol Dial Transpl"},{"key":"3786_CR13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.atherosclerosis.2018.01.011","volume":"270","author":"M Bozic","year":"2018","unstructured":"Bozic M, M\u00e9ndez-Barbero N, Guti\u00e9rrez-Mu\u00f1oz C, Betriu A, Egido J, Fern\u00e1ndez E, et al. Combination of biomarkers of vascular calcification and sTWEAK to predict cardiovascular events in chronic kidney disease. Atherosclerosis. 2018;270:13\u201320.","journal-title":"Atherosclerosis"},{"key":"3786_CR14","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1001\/jama.293.14.1737","volume":"293","author":"MG Shlipak","year":"2005","unstructured":"Shlipak MG, Fried LF, Cushman M, Manolio TA, Peterson D, Stehman-Breen C, et al. Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors. JAMA. 2005;293:1737\u201345.","journal-title":"JAMA"},{"key":"3786_CR15","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1056\/NEJMoa041031","volume":"351","author":"AS Go","year":"2004","unstructured":"Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C-Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296\u2013305.","journal-title":"N Engl J Med"},{"key":"3786_CR16","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1159\/000529791","volume":"13","author":"LCM Smit","year":"2023","unstructured":"Smit LCM, van der Bots ML, Damen JAAG, Blankestijn PJ, Verhaar MC, et al. One heartbeat away from a Prediction Model for Cardiovascular diseases in patients with chronic kidney disease: a systematic review. Cardiorenal Med. 2023;13:109\u201342.","journal-title":"Cardiorenal Med"},{"key":"3786_CR17","doi-asserted-by":"crossref","unstructured":"Sullivan LM, Massaro JM, D\u2019Agostino RB, Sr. Presentation of multivariate data for clinical use: the Framingham Study risk score functions. Stat Med. 2004;23:1631\u201360.","DOI":"10.1002\/sim.1742"},{"key":"3786_CR18","first-page":"261","volume":"281","author":"TJ Cole","year":"1993","unstructured":"Cole TJ, Algorithm AS. Scaling and rounding regression coefficients to integers. J R Stat Soc Ser C Appl Stat. 1993;281:42: 261\u20138.","journal-title":"J R Stat Soc Ser C Appl Stat"},{"key":"3786_CR19","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/S0895-4356(01)00341-9","volume":"54","author":"EW Steyerberg","year":"2001","unstructured":"Steyerberg EW, Harrell FE Jr, Borsboom GJ, Eijkemans MJ, Vergouwe Y, Habbema JD. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol. 2001;54:774\u201381.","journal-title":"J Clin Epidemiol"},{"key":"3786_CR20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1373\/clinchem.2007.096529","volume":"54","author":"NR Cook","year":"2008","unstructured":"Cook NR. Statistical evaluation of prognostic versus diagnostic models: beyond the ROC curve. Clin Chem. 2008;54:17\u201323.","journal-title":"Clin Chem"},{"key":"3786_CR21","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1006\/jmps.1999.1279","volume":"44","author":"MW Browne","year":"2000","unstructured":"Browne MW. Cross-validation methods. J Math Psychol. 2000;44:108\u201332.","journal-title":"J Math Psychol"},{"key":"3786_CR22","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","volume":"15","author":"FE Harrell Jr","year":"1996","unstructured":"Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361\u201387.","journal-title":"Stat Med"},{"key":"3786_CR23","doi-asserted-by":"publisher","first-page":"596","DOI":"10.7326\/0003-4819-158-8-201304160-00004","volume":"158","author":"N Tangri","year":"2013","unstructured":"Tangri N, Kitsios GD, Inker LA, Griffith J, Naimark DM, Walker S, et al. Risk prediction models for patients with chronic kidney disease: a systematic review. Ann Intern Med. 2013;158:596\u2013603.","journal-title":"Ann Intern Med"},{"key":"3786_CR24","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.amjcard.2004.03.023","volume":"94","author":"DM Lloyd-Jones","year":"2004","unstructured":"Lloyd-Jones DM, Wilson PWF, Larson MG, Beiser A, Leip EP, D\u2019Agostino RB, et al. Framingham risk score and prediction of lifetime risk for coronary heart disease. Am J Cardiol. 2004;94:20\u20134.","journal-title":"Am J Cardiol"},{"key":"3786_CR25","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1161\/CIRCULATIONAHA.105.584102","volume":"113","author":"WC Levy","year":"2006","unstructured":"Levy WC, Mozaffarian D, Linker DT, Sutradhar SC, Anker SD, Cropp AB, et al. The Seattle Heart failure model: prediction of survival in heart failure. Circulation. 2006;113:1424\u201333.","journal-title":"Circulation"},{"key":"3786_CR26","doi-asserted-by":"publisher","first-page":"304","DOI":"10.5551\/jat.ER48843","volume":"28","author":"M Nakai","year":"2021","unstructured":"Nakai M, Watanabe M, Kokubo Y, Nishimura K, Higashiyama A, Takegami M, et al. Development of a Cardiovascular Disease Risk Prediction Model using the Suita Study, a Population-based prospective cohort study in Japan. J Atheroscler Thromb. 2021;28:304.","journal-title":"J Atheroscler Thromb"},{"key":"3786_CR27","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.5551\/jat.ER61960","volume":"30","author":"T Honda","year":"2023","unstructured":"Honda T, Chen S, Hata J, Yoshida D, Hirakawa Y, Furuta Y, et al. Development and validation of a risk prediction model for atherosclerotic Cardiovascular Disease in Japanese adults: the Hisayama Study. J Atheroscler Thromb. 2023;30:1966\u20137.","journal-title":"J Atheroscler Thromb"},{"key":"3786_CR28","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1586\/14737167.2015.1012069","volume":"15","author":"TW Ferguson","year":"2015","unstructured":"Ferguson TW, Tangri N, Rigatto C, Komenda P. Cost-effective treatment modalities for reducing morbidity associated with chronic kidney disease. Expert Rev Pharmacoecon Outcomes Res. 2015;15:243\u201352.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"3786_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000506966","volume":"50","author":"PK-T Li","year":"2021","unstructured":"Li PK-T, Garcia-Garcia G, Lui S-F, Andreoli S, Fung WW-S, Hradsky A, et al. Kidney health for everyone everywhere - from Prevention to Detection and Equitable Access to Care. Blood Purif. 2021;50:1\u20138.","journal-title":"Blood Purif"},{"key":"3786_CR30","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1681\/ASN.2006101081","volume":"18","author":"DM Kent","year":"2007","unstructured":"Kent DM, Jafar TH, Hayward RA, Tighiouart H, Landa M, de Jong P, et al. Progression risk, urinary protein excretion, and treatment effects of angiotensin-converting enzyme inhibitors in nondiabetic kidney disease. J Am Soc Nephrol. 2007;18:1959\u201365.","journal-title":"J Am Soc Nephrol"},{"key":"3786_CR31","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1161\/01.STR.0000249054.96644.c6","volume":"37","author":"DM Kent","year":"2006","unstructured":"Kent DM, Selker HP, Ruthazer R, Bluhmki E, Hacke W. The stroke-thrombolytic predictive instrument: a predictive instrument for intravenous thrombolysis in acute ischemic stroke. Stroke. 2006;37:2957\u201362.","journal-title":"Stroke"},{"key":"3786_CR32","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1253\/circj.CJ-21-1041","volume":"86","author":"S Nakano","year":"2022","unstructured":"Nakano S, Kohsaka S, Chikamori T, Fukushima K, Kobayashi Y, Kozuma K, et al. JCS 2022 Guideline focused update on diagnosis and treatment in patients with stable coronary artery disease. Circ J. 2022;86:882\u2013915.","journal-title":"Circ J"},{"key":"3786_CR33","doi-asserted-by":"publisher","first-page":"3516","DOI":"10.1007\/s00330-020-06690-3","volume":"30","author":"W Cheng","year":"2020","unstructured":"Cheng W, Wu X, Liu Q, Wang H-S, Zhang N-Y, Xiao Y-Q, et al. Post-contrast acute kidney injury in a hospitalized population: short-, mid-, and long-term outcome and risk factors for adverse events. Eur Radiol. 2020;30:3516\u201327.","journal-title":"Eur Radiol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03786-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-024-03786-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03786-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T13:04:21Z","timestamp":1728479061000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-024-03786-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,9]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3786"],"URL":"https:\/\/doi.org\/10.1186\/s12882-024-03786-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4531495\/v1","asserted-by":"object"}]},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,9]]},"assertion":[{"value":"5 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was waived as the study used anonymized and de-identified data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Consent to participate was waived due to the use of anonymized and de-identified data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable as the data used were anonymized and did not involve any individual person\u2019s data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"339"}}